Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Topic / Pathology
- Parkinson's Disease
Objectives
To have more informations, click on the link below:
https://clinicaltrials.gov/ct2/show/NCT03318523?term=BIOGEN&cond=BIIB054
Sponsor
Biogen
Scientific publication(s)
-
Lang AE et al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387(5):408-420.
Status
Published results
